Research and Development (R&D) at NPRA

Research and Development (R&D) at NPRA


As a national regulatory agency, research is essential for NPRA to generate data as well as develop tools and policies to continuously improve decision making and regulatory activities. Publication of the research may allow NPRA to share our findings with a wider community, including other researchers, industry, healthcare professionals, and the general public. The dissemination of knowledge helps to advance the field and drive progress across various domains.

The NPRA Research and Development (R&D) Committee was established to plan, coordinate and monitor all R&D activities involving NPRA. The committee strives to foster an environment of curiosity, thus promoting better research culture within NPRA. Besides efforts to increase publications and presentations at both the national and international level, NPRA is taking steps to increase collaborative research with universities and other organisations.      

NPRA R&D Committee (2024-2026)


Chairperson: Dr. Noraisyah binti Mohd. Sani

Deputy chairperson: Dr. Rema Panickar a/p Sugunan @ Vasanthan

Secretary: Dr. Phuar Hsiao Ling

Committee members:

  1. Dr. Evelyn Loh Yun Xi
  2. Dr. Tee Khim Boon
  3. Pn. Aiza Adlina Abdullah
  4. En. Cheong Ooi Jin
  5. En. Muhd. Hilmi bin Mohtar
  6. En. Lim Wen Jun
  7. Pn. Suhasinee Subramaniam
  8. Pn. Meera Kumari a/p Ram Navas
  9. Dr. Nur Dayana Nisbar

Contact details:


For further information on research at NPRA and collaboration proposals: please send us an email at

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400



Image   Image   Image   Image  


The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Thursday 13 June 2024, 10:32:42.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA


Main Menu English